|
市場調査レポート
商品コード
1291591
一般用医薬品(OTC)市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測Over The Counter (OTC) Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。 |
一般用医薬品(OTC)市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測 |
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2~3営業日
|
世界の一般用医薬品(OTC)医薬品市場規模は、2022年に1,588億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に6.24%の成長率(CAGR)を示し、2028年までに2,317億米ドルに達すると予想しています。
一般用医薬品(OTC)医薬品は、非処方箋薬としても知られており、処方箋やヘルスケア専門家による治療を受ける必要なく使用することができます。OTC医薬品は安全で効果的であり、疼痛、咳や風邪、下痢、便秘、にきび、繰り返す片頭痛やアレルギーの治療に役立ちます。現在、世界中の薬局、コンビニエンスストア、スーパーマーケット、ガソリンスタンドで購入することができます。
軽度の疾病を治療するためにOTC医薬品を利用する人が増えていることは、市場の成長を促進する重要な要因の一つです。また、制酸剤、ヒスタミン2(H2)ブロッカー、プロトンポンプ阻害剤(PPI)などの一般用医薬品は、胸焼けや消化不良を緩和・予防するために使用されています。また、コロナウイルス感染症(COVID-19)の発生により、セルフケアの重要性に対する個人の意識が高まっています。このことが、栄養補助食品の売上を増加させ、市場の成長を強めています。さらに、主要企業は、消費者層を拡大し、地理的な存在感を高めるために、製品ポートフォリオを拡大しています。これは、規制当局による処方薬のOTC薬への切り替え認可の増加と相まって、市場にプラスの影響を及ぼしています。これとは別に、現在、ヘルスケア費用の増加を理由に、医師に相談せずにOTC医薬品を選択する人が増えています。さらに、セルフメディケーションの実践は、慢性疾患のコントロール、欠勤の減少、軽症時の医療資源の枯渇を防ぐことに役立ちます。その他、世界の老人人口の増加、流通チャネルの急速な拡大、製薬業界の著しい成長などが、全体の売上と収益性を押し上げています。
The global over the counter (OTC) drugs market size reached US$ 158.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 231.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.24% during 2023-2028.
Over the counter (OTC) drugs, also known as non-prescription drugs, can be used without a prescription or the need for seeking treatment by a healthcare professional. They are safe and effective and help cure pain, cough and cold, diarrhea, constipation, acne and manage recurring migraines and allergies. They are currently available in pharmacies, convenience stores, supermarkets and gas stations across the globe.
The increasing utilization of OTC drugs to treat minor ailments among individuals represents one of the key factors bolstering the market growth. Besides this, OTC medications, such as antacids, histamine-2 (H2) blockers, and proton pump inhibitors (PPIs), are used to relieve and prevent heartburn or acid indigestion. In addition, due to the coronavirus disease (COVID-19) outbreak, there is a rise in awareness among individuals about the importance of self-care. This, in turn, is increasing the sales of nutritional supplements and strengthening the market growth. Moreover, key players are expanding their product portfolio to widen their consumer base and increase their geographical presence. This, coupled with the increasing approvals from regulatory bodies for switching prescription drugs to OTC drugs, is positively influencing the market. Apart from this, there is currently an increase in the number of people opting for OTC drugs rather than consulting physicians on account of increasing healthcare costs. Furthermore, self-medication practices can assist in controlling chronic diseases, reducing absenteeism from work, and saving scarce medical resources from being exhausted during minor conditions. Some of the other factors, such as the rising geriatric population worldwide, rapid expansion of distribution channels, and significant growth in the pharmaceutical industry, are driving the overall sales and profitability.
IMARC Group provides an analysis of the key trends in each sub-segment of the global over the counter (OTC) drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, route of administration, dosage form and distribution channel.
Cough, Cold and Flu Products
Analgesics
Dermatology Products
Gastrointestinal Products
Vitamins, Minerals and Supplements (VMS)
Weight-loss/Dietary Products
Ophthalmic Products
Sleeping Aids
Others
Oral
Parenteral
Topical
Others
Tablets and Capsules
Liquids
Ointments
Others
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Alkem Laboratories Limited, Bayer AG, Daiichi Sankyo Company Limited, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Perrigo Company plc, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd.
Key Questions Answered in This Report
1. What was the size of the global over the counter (OTC) drugs market in 2022?
2. What is the expected growth rate of the global over the counter (OTC) drugs market during 2023-2028?
3. What are the key factors driving the global over the counter (OTC) drugs market?
4. What has been the impact of COVID-19 on the global over the counter (OTC) drugs market?
5. What is the breakup of the global over the counter (OTC) drugs market based on the product type?
6. What is the breakup of the global over the counter (OTC) drugs market based on the route of administration?
7. What is the breakup of the global over the counter (OTC) drugs market based on the dosage form?
8. What is the breakup of the global over the counter (OTC) drugs market based on the distribution channel?
9. What are the key regions in the global over the counter (OTC) drugs market?
10. Who are the key players/companies in the global over the counter (OTC) drugs market?